G

P

GHIORZO , P.

Last name: GHIORZO

First name: P.

2015 (v1)

Publication

Metadata-only

BRAF-mutant melanoma: Treatment approaches, resistance mechanisms, and diagnostic strategies

Spagnolo, F. Ghiorzo, P. Orgiano, L.

BRAF inhibitors vemurafenib and dabrafenib achieved improved overall survival over chemotherapy and have been approved for the treatment of BRAF-mutated metastatic melanoma. More recently, the combination of BRAF inhibitor dabrafenib with MEK inhibitor trametinib has shown improved progression-free survival, compared to dabrafenib monotherapy,...

Uploaded on: February 14, 2024